# FDA Inspection 808994 - Daxor Corporation - November 27, 2012

Source: https://www.keypedia.com/records/fda_inspections/daxor-corporation/7789373e-3f91-4435-83e1-98924591cb77
Source feed: FDA_Inspections

> FDA Inspection 808994 for Daxor Corporation on November 27, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808994
- Company Name: Daxor Corporation
- Inspection Date: 2012-11-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1166617 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/daxor-corporation/ab6806fb-e0cd-4e0e-8337-dad072412e01)
- [FDA Inspection 1166617 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/daxor-corporation/0bb822c5-b027-422c-9c8c-82a744d67515)
- [FDA Inspection 820341 - 2013-02-25](https://www.keypedia.com/records/fda_inspections/daxor-corporation/57788055-2eca-4cf1-ba81-7680efbef323)
- [FDA Inspection 820341 - 2013-02-25](https://www.keypedia.com/records/fda_inspections/daxor-corporation/31a8f421-8197-4862-8a89-b5367296d8c4)
- [FDA Inspection 674737 - 2010-08-04](https://www.keypedia.com/records/fda_inspections/daxor-corporation/9c2c1ead-55f3-49d5-a185-dfd8e56abe72)

Company: https://www.keypedia.com/companies/daxor-corporation/b76d5e66-ca74-4d1d-b28f-2c13c9fc56b7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c